It is aimed at making the PI3K/Akt/mTOR pathway a critical research target for understanding the development and progression of this disease, and the importance of this pathway as a potential therapeutic approach along with the prognostic and diagnostic value of this pathway in patients with breast cancer is undeniable [82, 83]. The gene discussed is MTOR; the disease is breast carcinoma.